Recent Quotes (30 days)

You have no recent quotes
chg | %

SQI Diagnostics Inc.  

(Public, CVE:SQD)   Watch this stock  
Find more results for SQD
0.000 (0.00%)
Jul 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.25 - 0.71
Open     -
Vol / Avg. 0.00/518.00
Mkt cap 30.06M
P/E     -
Div/yield     -
EPS -0.11
Shares 61.72M
Beta 1.51
Inst. own     -
May 22, 2015
Q2 2015 SQI Diagnostics Inc Earnings Call - Webcast
May 21, 2015
Q2 2015 SQI Diagnostics Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -2304.29% -4588.23%
Operating margin -2215.71% -4605.04%
EBITD margin - -3968.07%
Return on average assets -160.80% -116.21%
Return on average equity -255.87% -128.32%
Employees 33 -
CDP Score - -


36 Meteor Drive
+1-416-6749500 (Phone)
+1-416-6749300 (Fax)

Website links


SQI Diagnostics Inc. (SQI) is a Canada-based life sciences company. The Company develops and commercializes technologies and products for advanced multiplexing diagnostics. The Company has focused on product research, development and commercialization activities. The Company provides immunogenicity and bioanalysis; in vitro diagnostics (IVD) and clinical; biomarkers, which generate quantitative, clinical-grade data while multiplexing, and assay development. The Company’s products include SQiDworks, sqidlite and sqid-X.

Officers and directors

Andrew Morris President, Chief Executive Officer, Director
Lennie Ryer Chief Financial Officer
Age: 54
Patricia Lie Director of Finance (acting in the capacity of CFO)
Catherine Smith Vice President - Technology
Jaymie R. Sawyer Vice President - Research & Development
Peter D. Winkley Chairman of the Board
Clive J. Beddoe Director
Age: 68
Gerald R. Connor Director
Age: 69
Wilmot L. Matthews Director
Age: 77
Cameron R. Prange Director